HK1173469A1 - 由聚合物蛋白質綴合物形成的支架、其產生方法及其用途 - Google Patents
由聚合物蛋白質綴合物形成的支架、其產生方法及其用途Info
- Publication number
- HK1173469A1 HK1173469A1 HK13100803.2A HK13100803A HK1173469A1 HK 1173469 A1 HK1173469 A1 HK 1173469A1 HK 13100803 A HK13100803 A HK 13100803A HK 1173469 A1 HK1173469 A1 HK 1173469A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polymer
- methods
- protein conjugates
- generating same
- scaffolds formed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28210409P | 2009-12-16 | 2009-12-16 | |
PCT/IL2010/001072 WO2011073991A1 (en) | 2009-12-16 | 2010-12-16 | Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1173469A1 true HK1173469A1 (zh) | 2013-05-16 |
Family
ID=43632644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13100803.2A HK1173469A1 (zh) | 2009-12-16 | 2013-01-18 | 由聚合物蛋白質綴合物形成的支架、其產生方法及其用途 |
Country Status (9)
Country | Link |
---|---|
US (2) | US8846020B2 (zh) |
EP (1) | EP2513294B1 (zh) |
CN (2) | CN106039401A (zh) |
CA (1) | CA2783000A1 (zh) |
DK (1) | DK2513294T3 (zh) |
ES (1) | ES2573507T3 (zh) |
HK (1) | HK1173469A1 (zh) |
IL (1) | IL220343B (zh) |
WO (1) | WO2011073991A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7842667B2 (en) * | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
EP1722834B1 (en) | 2003-12-22 | 2012-06-27 | Regentis Biomaterials Ltd. | Matrix comprising naturally-occurring crosslinked protein backbone |
US8846003B2 (en) | 2008-03-27 | 2014-09-30 | Symic Biomedical, Inc. | Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
CN106039401A (zh) * | 2009-12-16 | 2016-10-26 | 瑞吉恩提斯生物材料有限公司 | 由聚合物‑蛋白质结合物形成的支架,产生该支架的方法及其用途 |
US20150147287A1 (en) * | 2011-05-20 | 2015-05-28 | International Flavors & Fragrances Inc. | Low volatile reactive malodor counteractives and methods of use thereof |
BR112013030086A2 (pt) | 2011-05-24 | 2022-03-03 | Purdue Research Foundation | Peptideoglicanos sintéticos que se ligam ao ácido hialurônico, matriz de colágeno engenheirada e seus usos |
EP2714093A1 (en) * | 2011-05-27 | 2014-04-09 | Baxter International Inc. | Therapeutic proteins with increased half-life and methods of preparing same |
MX2015012608A (es) | 2013-03-15 | 2016-07-06 | Symic Biomedical Inc | Peptidos sinteticos de union a matriz extracelular. |
CN107281545A (zh) * | 2013-06-27 | 2017-10-24 | 里捐提司生物材料有限公司 | 包含聚合物蛋白质偶联物及环境响应性聚合物的组成物及其应用 |
US10173357B2 (en) | 2013-09-26 | 2019-01-08 | Northwestern University | Poly(ethylene glycol) cross-linking of soft materials to tailor viscoelastic properties for bioprinting |
US9587221B2 (en) | 2013-11-11 | 2017-03-07 | Auburn University | Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels |
US10772931B2 (en) | 2014-04-25 | 2020-09-15 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
WO2017015703A1 (en) | 2015-07-24 | 2017-02-02 | The University Of Sydney | Antiseptic polymer and synthesis thereof |
WO2017103914A1 (en) * | 2015-12-17 | 2017-06-22 | Regentis Biomaterials Ltd. | Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof |
US20190083642A1 (en) | 2016-03-30 | 2019-03-21 | Regentis Biomaterials Ltd. | Treatments utilizing a polymer-protein conjugate |
EP3648774A4 (en) | 2017-07-07 | 2021-04-21 | Symic IP, LLC | SYNTHETIC ORGANIC CONJUGATES |
CN107233619A (zh) * | 2017-07-14 | 2017-10-10 | 中国人民解放军第四军医大学 | 一种功能化的多孔钛金属骨植入材料及其制备方法 |
JP7096324B2 (ja) * | 2018-03-20 | 2022-07-05 | 三井化学株式会社 | 硬組織補修用組成物及び硬組織補修用キット |
CN114887123B (zh) * | 2022-04-18 | 2023-07-04 | 南通大学 | 水蛭素接枝纳米纤维血管支架材料、制备方法与应用 |
CN114767926B (zh) * | 2022-05-24 | 2023-06-20 | 上海健康医学院 | 一种3d打印自组装的介孔生物玻璃多孔支架的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7842667B2 (en) | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
EP1722834B1 (en) | 2003-12-22 | 2012-06-27 | Regentis Biomaterials Ltd. | Matrix comprising naturally-occurring crosslinked protein backbone |
US20060034889A1 (en) | 2004-08-16 | 2006-02-16 | Macromed, Inc. | Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof |
KR100784485B1 (ko) | 2006-01-18 | 2007-12-11 | 한국과학기술연구원 | 생분해성 온도 감응성 폴리포스파젠계 하이드로젤, 그의제조방법 및 그의 용도 |
WO2007107012A1 (en) * | 2006-03-23 | 2007-09-27 | Citagenix Inc. | Reverse phase osteoconductive composition |
PT2150282T (pt) | 2007-04-16 | 2018-07-09 | Regentis Biomaterials Ltd | Composições e métodos para formação do suporte |
JP2009283287A (ja) * | 2008-05-22 | 2009-12-03 | Yazaki Corp | アルミ電線用圧着端子 |
WO2009142770A2 (en) * | 2008-05-23 | 2009-11-26 | The Regents Of The University Of California | Compositions and methods for generating musculoskeletal tissue |
CN106039401A (zh) * | 2009-12-16 | 2016-10-26 | 瑞吉恩提斯生物材料有限公司 | 由聚合物‑蛋白质结合物形成的支架,产生该支架的方法及其用途 |
-
2010
- 2010-12-16 CN CN201610373873.6A patent/CN106039401A/zh active Pending
- 2010-12-16 DK DK10803152.7T patent/DK2513294T3/en active
- 2010-12-16 WO PCT/IL2010/001072 patent/WO2011073991A1/en active Application Filing
- 2010-12-16 EP EP10803152.7A patent/EP2513294B1/en active Active
- 2010-12-16 ES ES10803152.7T patent/ES2573507T3/es active Active
- 2010-12-16 CA CA2783000A patent/CA2783000A1/en not_active Abandoned
- 2010-12-16 CN CN201080057801.1A patent/CN102762715B/zh active Active
- 2010-12-16 US US13/515,298 patent/US8846020B2/en active Active
-
2012
- 2012-06-12 IL IL220343A patent/IL220343B/en active IP Right Grant
-
2013
- 2013-01-18 HK HK13100803.2A patent/HK1173469A1/zh not_active IP Right Cessation
-
2014
- 2014-09-09 US US14/480,778 patent/US20140377209A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140377209A1 (en) | 2014-12-25 |
CN102762715A (zh) | 2012-10-31 |
CN106039401A (zh) | 2016-10-26 |
WO2011073991A1 (en) | 2011-06-23 |
EP2513294B1 (en) | 2016-04-13 |
DK2513294T3 (en) | 2016-06-06 |
EP2513294A1 (en) | 2012-10-24 |
CA2783000A1 (en) | 2011-06-23 |
US20120258068A1 (en) | 2012-10-11 |
ES2573507T3 (es) | 2016-06-08 |
IL220343B (en) | 2018-11-29 |
CN102762715B (zh) | 2016-06-22 |
US8846020B2 (en) | 2014-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1173469A1 (zh) | 由聚合物蛋白質綴合物形成的支架、其產生方法及其用途 | |
IL243932A0 (en) | Certain chemical entities, preparations and methods | |
HK1194071A1 (zh) | 某些三唑並吡嗪、其組合物及其用法 | |
GB0917044D0 (en) | Agents, uses and methods | |
GB0917054D0 (en) | Agents, uses and methods | |
EP2248171A4 (en) | SEMICONDUCTOR CONSTRUCTIONS AND METHODS OF FORMING SEMICONDUCTOR CONSTRUCTIONS | |
IL214539A0 (en) | Fibronectin type iii domain based scaffold compositions, methods and uses | |
GB0902052D0 (en) | Polymers,composition and use | |
EP2268673A4 (en) | POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF | |
EP2561072A4 (en) | NANOZYMES, PROCESSES FOR PRODUCING NANOZYMES, AND METHODS OF USING NANOZYMES | |
EP2519290A4 (en) | DENTAL SELF-MIXING PROCEDURES, DEVICES AND COMPOSITIONS | |
AP2011005800A0 (en) | Purified plasmodium and vaccine compositions. | |
EP2416801A4 (en) | IMMUNOGENIC COMPOSITION AND ITS USES | |
EP2245113A4 (en) | PHOSPHORESCENT COMPOSITIONS, METHODS FOR PREPARING THE COMPOSITIONS, AND METHODS OF USING THE COMPOSITIONS | |
EP2285405A4 (en) | VACCINE COMPOSITIONS AND METHODS | |
EP2414321A4 (en) | HYDROPHOBIC MONOMERS, HYDROPHOBICALLY DERIVATIVE MEDIA AND METHODS OF MAKING AND USING THEM | |
EP2515940A4 (en) | IMMUNOGENIC COMPOSITIONS AND CORRESPONDING METHODS | |
EP2289104A4 (en) | DIODES AND METHOD FOR FORMING DIODES | |
EP2438173A4 (en) | BIOMATERIALS, COMPOSITIONS AND METHODS | |
GB0901494D0 (en) | Compositions and Methods | |
EP2296675A4 (en) | ECHINODERM EXTRACTS, MANUFACTURING METHODS AND ITS USES | |
EP2470591A4 (en) | SUPERCHOC POLYMERS, THEIR METHODS OF MANUFACTURE AND USE | |
GB201004487D0 (en) | Catalyst compositions, method of making the same and methods of making hydrogen peroxide | |
EP2350212A4 (en) | POLYAMINO-ACETONITRILES, PROCESSES FOR PREPARING THEM AND USE THEREOF | |
GB0811210D0 (en) | Improvements related to the authentication of messages |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211213 |